Form 4 for LYEL Lyell Immunopharma, Inc.
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-10 · accession 0002095702-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-11 | 2026-02-10 | LYEL | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $23.12 | -254 | 15.6K | -2% | -$5,872 | |
| 2026-02-11 | 2026-02-10 | LYEL | Bulis Veronica Sanchez | VP, Corp. Ctrl | A - Grant | $0.00 | +8,750 | 15.9K | +123% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | S | D | 254 | $23.12 | 15,637 | D | — | — | (F2) Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |
| 2 | Common | Common Stock | 2026-02-10 | A | A | 8,750 | $0.00 | 15,891 | D | — | — | (F1) Represents restricted stock units granted under the Issuer's 2021 Equity Incentive Plan. 12.5% of the total number of restricted stock units will vest on August 9, 2026, and thereafter an additional 1/16th of the total number of restricted stock units will vest quarterly thereafter, subject to the reporting person providing service through the applicable vesting date. |